Filing Details
- Accession Number:
- 0001209191-19-057115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 16:03:59
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-19 16:03:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711279 | Krystal Biotech Inc. | KRYS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298709 | S Krish Krishnan | C/O Krystal Biotech, Inc. 2100 Wharton Street, Suite 701 Pittsburgh PA 15203 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-15 | 11,895 | $49.72 | 2,024,567 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-15 | 11,386 | $50.69 | 2,013,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-15 | 4,598 | $51.47 | 2,008,583 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 1,046 | $50.98 | 2,007,537 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 10,513 | $51.82 | 1,997,024 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 8,080 | $52.68 | 1,988,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 2,082 | $53.86 | 1,986,862 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 400 | $54.38 | 1,986,462 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 112,162 | Indirect | By trust |
| Common Stock | 2,001,462 | Indirect | By spouse |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors.
- This transaction was executed in multiple trades ranging from $49.16 to $50.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $50.16 to $51.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $51.235 to $51.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $50.29 to $51.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $51.31 to $52.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $52.31 to $53.215. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $53.35 to $54.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $54.35 to $54.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control.
- Directly beneficially owned by Suma S. Krishnan, the spouse of the reporting person.
Billionaire Hedge Funds
